XML 14 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Beginning balance, value at Dec. 31, 2023 $ 90,593 $ 75 $ 14,972 $ (6,431) $ 109,959 $ (27,982)
Balance (in shares) at Dec. 31, 2023   5,735,075        
Net income 2,107       2,107  
Net change in fair value of securities available-for-sale, net of tax (73)     (73)    
Net change in fair value of derivative instruments, net of tax (117)     (117)    
Dividends declared (289)       (289)  
Impact of stock-based compensation plans, net 105   150     (45)
Reissuance of treasury stock as compensation (in shares)   52,366        
Ending balance, value at Mar. 31, 2024 92,326 $ 75 15,122 (6,621) 111,777 (28,027)
Balance (in shares) at Mar. 31, 2024   5,787,441        
Beginning balance, value at Dec. 31, 2024 98,624 $ 78 15,540 (4,344) 116,865 (29,515)
Balance (in shares) at Dec. 31, 2024   5,696,171        
Net income 1,772       1,772  
Net change in fair value of securities available-for-sale, net of tax 2,011     2,011    
Net change in fair value of derivative instruments, net of tax (341)     (341)    
Dividends declared (401)       (401)  
Impact of stock-based compensation plans, net 101 $ 1 202     (102)
Impact of stock-based compensation plans, net (in shares)   51,565        
Reissuance of treasury stock as compensation     (434)     434
Reissuance of treasury stock as compensation (in shares)   31,550        
Impact of common stock share repurchases (535)         (535)
Impact of common stock share repurchases (in shares)   (40,000)        
Ending balance, value at Mar. 31, 2025 $ 101,231 $ 79 $ 15,308 $ (2,674) $ 118,236 $ (29,718)
Balance (in shares) at Mar. 31, 2025   5,739,286